qPCR Lentivirus Titer Kit
| Cat. No. | LV900 | |||||||||||||||||||
| Name | qPCR Lentivirus Titer Kit | |||||||||||||||||||
| Unit | 100 rxn | |||||||||||||||||||
| Category | qPCR Virus Titer Kits | |||||||||||||||||||
| Description |
The only kit on the market with complete elimination of NTC! abm’s qPCR Lentivirus Titer Kit is a one-step assay that employs a quick RNA extraction step that is followed by RT-qPCR, offering high sensitivity and specificity for accurate lentivirus titer quantification. Designed to minimize non-specific background, this kit delivers superior performance compared to others on the market. The MasterMix contains a dye similar to SYBR Green™ and EvaGreen®, optimizing amplification efficiency, while the ROX Reference Dye is provided separately for broad compatibility with most qPCR instruments. For detailed instrument compatibility, refer to our ROX Machine Compatibility Chart. Kit Features:
|
|||||||||||||||||||
| Storage Condition |
Store at -20°C. This product is stable for 2 year from the date of shipping if stored and handled properly. |
|||||||||||||||||||
| Note |
qPCR Lentivirus Titer Kit comes with a separate vial of ROX Reference Dye which can be added depending on the qPCR machine type, as listed in the table below.
|
|||||||||||||||||||
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LV900 |
| Why do I get higher titers for the more diluted sample from the same stock? | |
|
This means your virus stock may have strong PCR inhibitors in the sample. Thus, it would best to trust the more diluted samples' results, as it lessens the inhibitor's influence.
|
| Will the transfected plasmids used to produce the lentiviral particles interfere with the qPCR results? What about the host's genome? | |
|
The transfection plasmids and host's genome remain in the packaging cells while the viral particles are harvested from the supernatant. The titering process will not involve the cells, thus the plasmids and genome will not interfere with the results as well.
|
| Can this kit titer FIV particles? | |
|
No, this kit cannot titer FIV particles.
|
| My experiment needs MOI=10. How can I know that viral particle? How to IU(infectious units)/ml convert to viral particle? | |
|
Multiplicity of Infection (MOI) Calculation Method: MOI = (Product Titer (IU/ml) x Virus Volume (ml)) /Total Cell Number For example, to achieve a MOI of 10 with a 1 x 10^6 IU/ml titer virus on 1 x 10^5cells, use 1.0 ml of the virus.
|
| Does your titration kit work with pLKO.1 based siRNA lentivirus? | |
|
Our titer kit should be able to detect pLKO.1 vector with an qPCR product size of about 100 bp.
|
| Can I use this kit to exclude the generation of replication competent lentivirus (RCL) in previously infected cells (stable cell lines?) so I can safely transfer them to Biosafety Level 1? | |
|
Yes, this kit can be used to determine that no replicative competent virus is being produced by previously infected cells. It is important to consult with the health and safety officer(s) at your own institution in order to determine if infected cells can be transferred to Biosafety Level 1.
|
| Is this kit suitable for titrating retroviruses and adenoviruses? | |
|
No, this kit is designed for Lentiviruses only.
|
| The dissociation curve shows that the Tm of my Lentivirus is lower than that of standards, why? | |
|
The Tm of a qPCR product is mainly depending on two variables: the reaction mixture's chemical compositions and the sequence of the amplicon. Since all the reactions in this case have almost the same compositions (ex: all the input templates are basically water, not for instant high salt template solution), the main variation would be in the template sequence. It is possible that your the vector has a slightly different sequence (likely having less GC content) than our std's sequence, thus having a lower Tm than the Std.
|
| Will the qPCR Lentivirus Titration(Titer) Kit amplify the integrated genomic region of the lentivirus? | |
|
No, the qPCR Lentivirus Titration (Titer) Kit (Cat#LV900) will not amplify the integrated genomic regions of lentivirus because the primers amplify the 5' LTR of the lentivirus.
|
| Does the assay detect free viral RNA and so overestimate the viral titer? If so, is there a way to minimize this? | |
|
In theory, it is possible for our Cat#LV900 to detect free viral RNA and free viral RNA can be present in the supernatant collected during lentivirus production, however this should not impact the titer to any significant extent and should be very minimal in detection, if any. If desired, you may wish to further purify your virus using our Ultra-Pure Lentivirus Purification Kit (Cat#LV998) or Speedy Lentivirus Purification (Cat#LV999) to remove any free viral RNA. However, we have never encountered any issues using our LV900 kit and free viral RNA has not been a factor; we use this kit regularly during our routine QC processes, and it is one of the most popular products in our catalogue.
|
| For lenti titering, is it possible to start with an ultracentrifuged lenti sample (suspended in PBS) as opposed to straight supernatant? | |
|
Yes, starting with an ultracentrifuged lenti sample should indeed be suitable for use with our qPCR Lentivirus Titration(Titer) Kit (LV900).
|
| Is this kit suitable for detecting both 2nd and 3rd generation lentivirus? | |
|
Yes, the kit is suitable for detecting both 2nd and 3rd generation lentivirus.
|
| What type of vectors will this kit work with? | |
|
The titer primers supplied in LV900 are designed for all HIV-1 based viral detection.
|
| Is DNAse treatment required after harvesting the lentivirus stock? | |
|
DNase treatment is not recommended. When packaging lentivirus, we recommend removing the transfection medium from the cells after overnight incubation, and replace with complete culture media for the cells. Incubate another 24 hours, and then collect the supernatant.
|
| What is the primer design based on? | |
|
The primers in this kit uses a set of proprietary sequences designed based on the 5'LTR region.
|
| How come my cells are not successfully infected with the evaluated titer from the kit? | |
|
One important thing to note is that the infection success is dependent on the cell type. Some cells may be more susceptible than others for viral infection. Thus, the same number of infectious units may perform differently on different cell types.
|
| Does the standard need to be diluted each time? Can diluted standards be used multiple times? | |
|
It is advised to dilute the standard fresh each time as the diluted standards might be degraded over time, thus compromising their accuracy.
|
| Does this have ROX reference dye? | |
|
abm's qPCR MasterMixes don't contain ROX dye, but it is provided in a separate tube when you purchase any abm qPCR MasterMix. Some qPCR machines may require ROX, so please consult our machine compatibility list on the product page to see if your instrument needs it.
|
| How much ROX reference dye should I add to the MasterMix? | |
|
The recommended volume of ROX reference dye varies based on the qPCR instrument:
|
| Can I use this MasterMix with any qPCR machine? | |
|
Yes, this MasterMix is universally compatible with most qPCR instruments, as the ROX dye is provided separately for flexibility.
|
- Zhou, X., LeBleu, V. S., Fletcher-Sananikone, E., Kim, J., Dai, J., Li, B., Wu, C.-C., Sugimoto, H., Miyake, T., Becker, L. M., Volpert, O. V., Lawson, E., Espinosa Da Silva, C., Patel, S. I., Kizu, A., Ehsanipour, E. A., Sha, D., Karam, J. A., McAndrews, K. M., & Kalluri, R. (2024). Vascular heterogeneity of tight junction Claudins guides organotropic metastasis. Nature Cancer, 5(9), 1371–1389. https://doi.org/10.1038/s43018-024-00813-1
-
Bayin, N.S., Placantonakis, D.G. (2018). Selective Targeting of CD133-Expressing Glioblastoma Stem Cells Using Lentiviral Vectors. In: Placantonakis, D. (eds) Glioblastoma. Methods in Molecular Biology, vol 1741. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7659-1_7
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (2023). Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method. Pharmaceutics, 15(2), 597. https://doi.org/10.3390/pharmaceutics15020597
Bodas, M., Subramaniyan, B., Moore, A. R., Metcalf, J. P., Ocañas, S. R., Freeman, W. M., ... & Walters, M. S. (2021). The NOTCH3 Downstream Target HEYL Regulates Human Airway Epithelial Club Cell Differentiation. bioRxiv, 2021-03. https://doi.org/10.1101/2021.03.10.434858
Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., ... & Castronovo, V. (2019). Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International journal of cancer, 145(6), 1570-1584. https://doi.org/10.1002/ijc.32247
Deroyer, C., Charlier, E., Neuville, S. et al. CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes. Cell Death Dis 10, 103 (2019). https://doi.org/10.1038/s41419-019-1377-8
Fettweis, G., Di Valentin, E., L'homme, L., Lassence, C., Dequiedt, F., Fillet, M., ... & Piette, J. (2017). RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1864(1), 113-124. https://doi.org/10.1016/j.bbamcr.2016.10.014
Kaur, B., Sharma, P.K., Chatterjee, B. et al. Defective quality control autophagy in Hyperhomocysteinemia promotes ER stress and consequent neuronal apoptosis through proteotoxicity. Cell Commun Signal 21, 258 (2023). https://doi.org/10.1186/s12964-023-01288-w
Kim, T. Y., Kim, J. Y., Kwon, H. C., Jeon, S., ji Lee, S., Jung, H., ... & Lee, C. J. (2022). Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation. Antiviral Research, 208, 105428. https://doi.org/10.1016/j.antiviral.2022.105428
Lerchner, W., Dash, K., Rose, D., Eldridge, M. A., Rothenhoefer, K. M., Yan, X., ... & Richmond, B. J. (2023). Efficient viral expression of a chemogenetic receptor in the old-world monkey amygdala. Current Research in Neurobiology, 4, 100091. https://doi.org/10.1016/j.crneur.2023.100091
Lerchner, W., Luz-Ricca, A., Dash, K., DerMinassian, V., Richmond, B.J. (2023). Production, Testing, and Verification of Lentivirus for Regional Targeting in the Old-World Monkey Brain. In: Eldridge, M.A., Galvan, A. (eds) Vectorology for Optogenetics and Chemogenetics. Neuromethods, vol 195. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2918-5_1
Steinbauer, S., Cowles, J. D., Sabbaghi, M. A., Poppelaars, M., Hussain, A., Wagesreither, M., ... & Csiszar, A. (2025). Enhanced AkaLuc Bioluminescence Imaging for Longitudinal Intravital Monitoring of Minimal Residual Disease in a Murine Model of Triple-negative Breast Cancer. bioRxiv, 2025-01. https://doi.org/10.1101/2025.01.18.633734
Tang, C. Y., Wang, H., Zhang, Y., Wang, Z., Zhu, G., McVicar, A., ... & Chen, W. (2022). GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways. International Journal of Biological Sciences, 18(6), 2392. https://doi.org/10.7150/ijbs.70620
Wang, M., Li, S., Guo, W., Wang, L., Huang, J., Zhuo, J., ... & Zhang, H. (2022). CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity. Carcinogenesis, 43(3), 264-276. https://doi.org/10.1093/carcin/bgab103
Won, J., Lee, S., Park, M., Kim, T. Y., Park, M. G., Choi, B. Y., ... & Lee, C. J. (2020). Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Experimental neurobiology, 29(2), 107. https://doi.org/10.5607/en20009
Wu, J., Rowart, P., Jouret, F., Gassaway, B. M., Rajendran, V., Rinehart, J., & Caplan, M. J. (2020). Mechanisms involved in AMPK-mediated deposition of tight junction components to the plasma membrane. American Journal of Physiology-Cell Physiology, 318(3), C486-C501. https://doi.org/10.1152/ajpcell.00422.2019
Zhang, Y., Wang, H., Zhu, G., Qian, A., & Chen, W. (2020). F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways. International journal of biological sciences, 16(9), 1629. https://doi.org/10.7150/ijbs.41867